Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

Related Videos

September 7, 2018

Who Should Consider Genetic Testing?

Dr Andrey Antov identifies situations in which people may want to consider genetic testing.

October 6, 2014

QOL Issues in Polycythemia Vera

Emily Knight presents why quality of life is a big issue in polycythemia vera and how she helps patients in management Supported through funding from Incyte